Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt

Details for Australian Patent Application No. 2002338897 (hide)

Owner Novartis AG

Inventors Rigassi, Thomas; Dederichs, Jurgen

Agent Davies Collison Cave

Pub. Number AU-B-2002338897

PCT Number PCT/EP02/11589

PCT Pub. Number WO2003/032978

Priority 0124953.1 17.10.01 GB

Filing date 16 October 2002

Wipo publication date 28 April 2003

Acceptance publication date 19 October 2006

International Classifications

A61K 31/365 (2006.01) - Lactones

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 0124953.1 17.10.01 GB

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002338897

19 October 2006 Application Accepted

  Published as AU-B-2002338897

29 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002338898-Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as gaba a receptor modulators

2002338896-Quinoline derivatives as ligands for the neuropeptide Y receptor